Degussa Aktiengesellschaft

Evonik Degussa Gmbh

Evonik Operations Gmbh

Winfried Heimbeck

Dieter Greissinger

Harald Jakob

Martin Koerfer

Georg Borchers

Herbert Tanner

Ulrike Kottke

Christian Rabe

Thomas Haeussner

Frank Fischer

Karsten Portner

Wolfgang Polzer

Wolfgang Moese

Nongyuan Shi-Muenzenberg

Heidermarie Kniesel

Hans Albrecht Hasseberg

Claudia Parys

A composition for feeding a ruminant, including i) a core including a biologically active ingredient selected from i) amino acids, ii) proteins, iii) peptides, iv) carbohydrates, v) vitamins, vi) probiotic microorganisms, vii) prebiotic foods, viii) choline and salts, and ix) polyunsaturated fatty acids (PUFAs); and ii) a coating surrounding said core. The coating includes one or more layers of a mixture including from 60 wt %+/−10% to 80 wt %+/−10% of a saturated fat and from 20 wt %+/−10% to 40 wt %+/−10% of a fatty acid, each based on the total weight of the coating. The composition includes from 5 wt %+/−10% to 30 wt %+/−10% of the coating, based on the total weight of the composition.

Rumen protected products

Active compound formulations for animal nutrition of amino acids, vitamins, enzymes and pigments, which are suitable for providing the active compounds in protected form for the nutrition of stock animals, in particular ruminants, and a process for the preparation of these protected active compound formulations.

Protected active compound formulations of amino acids and process for their preparation

A dosage form for administering physiologically active substances to animals, especially ruminant animals. The dosage unit includes a core which contains the active substance and a coating. The coating has selected areas which are thinner than the average thickness of the coating and/or areas which are predetermined rupture sites. These thin areas or predetermined rupture sites are constructed and arranged so as to detach and/or rupture under the conditions which are present after oral administration of the dosage form. As a result, the delayed release of the physiologically-active substance is accelerated. For example, the coating may be formulated to not be affected in the first stomach of a ruminant but to rapidly disintegrate in the animal's second stomach.

Active-substance preparation for oral administration, especially to

Growing community of inventors

Moembris, Germany

Winfried Heimbeck